Goods and Services and Canna Trademarks October 9, 2023 AggregatedNews Intellectual Property 0 Comments By Fred Rocafort, Attorney at Harris Sliwoski Goods and services (G&S) identifications are a critical part of a cannabis trademark application, as with any other trademark application. An improper identification can delay an application, and in the worst cases prove… Read More→
A Prescription for Progress? September 21, 2023 Benton Bodamer Policy & Legal 0 Comments Would a Schedule III Reclassification of Psychoactive Cannabis Help or Hurt State Operators? By Benton Bodamer, Member, Dickinson Wright PLLC, Adjunct Professor of Law, Drug Enforcement and Policy Center, Moritz College of Law, The Ohio State University I. Introduction On… Read More→
The FDA Continues to Show It Is Not Interested in Regulating Hemp-Derived Products August 23, 2021 AggregatedNews Hemp Policy & Legal 0 Comments by Natalie Bougenies, Attorney at Harris Bricken Last week, the Food and Drug Administration (the “FDA”) maintained its strict and narrow position on the legality of cannabidiol (“CBD”) by rejecting two new dietary ingredient (“NDI”) notifications submitted by Charlotte’s Web… Read More→
U.S. Senate’s Cannabis Administration and Opportunity Act Clarifies How Federal Government May Regulate Marijuana but Leaves Unanswered Questions July 21, 2021 Ian Stewart Federal 3 Comments The much-anticipated proposed Senate bill that would legalize marijuana on the federal level was made public on July 14, 2021, by its lead sponsor, Senate Majority Leader Charles Schumer (D-New York). Called the Cannabis Administration and Opportunity Act, it removes… Read More→
The “Right to Try” Psilocybin and New Drug Therapies November 11, 2020 AggregatedNews Oregon, Policy & Legal, Psychedelics 0 Comments by Vince Sliwoski, Attorney at Harris Bricken I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. We discussed how licensed facilities won’t be up and running for a few… Read More→